Authors:
Smith, JS
Tachibana, I
Passe, SM
Huntley, BK
Borell, TJ
Iturria, N
O'Fallon, JR
Schaefer, PL
Scheithauer, BW
James, CD
Buckner, JC
Jenkins, RB
Citation: Js. Smith et al., PTEN mutation, EGFR amplification, and outcome in patients with anaplasticastrocytoma and glioblastoma multiforme, J NAT CANC, 93(16), 2001, pp. 1246-1256
Authors:
Galanis, E
Bateman, A
Johnson, K
Diaz, RM
James, CD
Vile, R
Russell, SJ
Citation: E. Galanis et al., Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas, HUM GENE TH, 12(7), 2001, pp. 811-821
Authors:
Reiter, JL
Threadgill, DW
Eley, GD
Strunk, KE
Danielsen, AJ
Sinclair, CS
Pearsall, RS
Green, PJ
Yee, D
Lampland, AL
Balasubramaniam, S
Crossley, TD
Magnuson, TR
James, CD
Maihle, NJ
Citation: Jl. Reiter et al., Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms, GENOMICS, 71(1), 2001, pp. 1-20
Authors:
Burger, PC
Pearl, DK
Aldape, K
Yates, AJ
Scheithauer, BW
Passe, SM
Jenkins, RB
James, CD
Citation: Pc. Burger et al., Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?, J NE EXP NE, 60(11), 2001, pp. 1099-1104
Authors:
Erlichman, C
Boerner, SA
Hallgren, CG
Spieker, R
Wang, XY
James, CD
Scheffer, GL
Maliepaard, M
Ross, DD
Bible, KC
Kaufmann, SH
Citation: C. Erlichman et al., The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistanceprotein-mediated drug efflux, CANCER RES, 61(2), 2001, pp. 739-748
Authors:
Shridhar, V
Lee, J
Pandita, A
Iturria, S
Avula, R
Staub, J
Morrissey, M
Calhoun, E
Sen, A
Kalli, K
Keeney, G
Roche, P
Cliby, W
Lu, K
Schmandt, R
Mills, GB
Bast, RC
James, CD
Couch, FJ
Hartmann, LC
Lillie, J
Smith, DI
Citation: V. Shridhar et al., Genetic analysis of early- versus late-stage ovarian tumors, CANCER RES, 61(15), 2001, pp. 5895-5904
Authors:
Hirose, Y
Aldape, K
Bollen, A
James, CD
Brat, D
Lamborn, K
Berger, M
Feuerstein, BG
Citation: Y. Hirose et al., Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups, AM J PATH, 158(3), 2001, pp. 1137-1143
Authors:
Thomas, C
Ely, G
James, CD
Jenkins, R
Kastan, M
Jedlicka, A
Burger, P
Wharen, R
Citation: C. Thomas et al., Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells, ACT NEUROP, 101(6), 2001, pp. 605-615
Citation: L. Frederick et al., Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements, NEURO-ONCOL, 2(3), 2000, pp. 159-163
Authors:
Biegel, JA
Fogelgren, B
Zhou, JY
James, CD
Janss, AJ
Allen, JC
Zagzag, D
Raffel, C
Rorke, LB
Citation: Ja. Biegel et al., Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system, CLIN CANC R, 6(7), 2000, pp. 2759-2763
Authors:
Gutmann, DH
Donahoe, J
Brown, T
James, CD
Perry, A
Citation: Dh. Gutmann et al., Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas, NEUROP AP N, 26(4), 2000, pp. 361-367
Authors:
Gilhuis, HJ
Anderl, KL
Boerman, RH
Jeuken, JM
James, CD
Raffel, C
Scheithauer, BW
Jenkins, RB
Citation: Hj. Gilhuis et al., Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature, CLIN NEUROL, 102(4), 2000, pp. 203-209
Authors:
Smith, JS
Wang, XY
Qian, JQ
Hosek, SM
Scheithauer, BW
Jenkins, RB
James, CD
Citation: Js. Smith et al., Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features, J NE EXP NE, 59(6), 2000, pp. 495-503
Authors:
James, CD
Davis, R
Meyer, M
Turner, A
Turner, S
Withers, G
Kam, L
Banker, G
Craighead, H
Isaacson, M
Turner, J
Shain, W
Citation: Cd. James et al., Aligned microcontact printing of micrometer-scale poly-L-lysine structuresfor controlled growth of cultured neurons on planar microelectrode arrays, IEEE BIOMED, 47(1), 2000, pp. 17-21
Citation: L. Frederick et al., Diversity and frequency of Epidermal Growth Factor Receptor mutations in human glioblastomas, CANCER RES, 60(5), 2000, pp. 1383-1387
Citation: Jl. Reiter et al., Correspondence re: S. Shintani et al., intragenic mutation analysis of thehuman epidermal growth factor receptor (EGFR) gene in malignant human oralkeratinocytes. Cancer Res., 59 : 4142-4147, 1999., CANCER RES, 60(3), 2000, pp. 766-766
Authors:
Wu, GJ
Sinclair, CS
Paape, J
Ingle, JN
Roche, PC
James, CD
Couch, FJ
Citation: Gj. Wu et al., 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genes, CANCER RES, 60(19), 2000, pp. 5371-5375
Citation: Ed. Remstein et al., Incidence and subtype specificity of AP12-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas, AM J PATH, 156(4), 2000, pp. 1183-1188
Authors:
Bredel, M
Pollack, IF
Hamilton, RL
James, CD
Citation: M. Bredel et al., Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood, CLIN CANC R, 5(7), 1999, pp. 1786-1792
Authors:
Raffel, C
Frederick, L
O'Fallon, JR
Atherton-Skaff, P
Perry, A
Jenkins, RB
James, CD
Citation: C. Raffel et al., Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations, CLIN CANC R, 5(12), 1999, pp. 4085-4090
Citation: Tj. Hobbs et Cd. James, Influence of shade covers on pitfall trap temperatures and capture successof reptiles and small mammals in arid Australia, WILDLIF RES, 26(3), 1999, pp. 341-349